Assembly Biosciences Q4 EPS $1.30 Beats $(0.65) Estimate, Sales $42.469M Beat $7.423M Estimate

Assembly Biosciences (NASDAQ: ASMB) reported Q4 earnings of $1.30 per share, surpassing the analyst estimate of $(0.65) by 300%, and showing a 182.8% improvement from a loss of $(1.57) per share in the previous year. The company also achieved quarterly sales of $42.469 million, exceeding expectations by 472.15% and reflecting a 477.26% increase from $7.357 million in the same quarter last year.